brain cancer imaging

MELBOURNE, Australia and INDIANAPOLIS, United States, March 16, 2026 Telix Pharmaceuticals has announced the resubmission of a New Drug...

MELBOURNE, AUSTRALIA & INDIANAPOLIS, UNITED STATES — February 18, 2026 Telix Pharmaceuticals has submitted a European Marketing Authorization Application...